1-17278206-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_016233.2(PADI3):​c.1555+1330G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.56 in 152,124 control chromosomes in the GnomAD database, including 24,396 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.56 ( 24396 hom., cov: 34)

Consequence

PADI3
NM_016233.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.08

Publications

6 publications found
Variant links:
Genes affected
PADI3 (HGNC:18337): (peptidyl arginine deiminase 3) This gene encodes a member of the peptidyl arginine deiminase family of enzymes, which catalyze the post-translational deimination of proteins by converting arginine residues into citrullines in the presence of calcium ions. The family members have distinct substrate specificities and tissue-specific expression patterns. The type III enzyme modulates hair structural proteins, such as filaggrin in the hair follicle and trichohyalin in the inner root sheath, during hair follicle formation. Together with the type I enzyme, this enzyme may also play a role in terminal differentiation of the epidermis. This gene exists in a cluster with four other paralogous genes. [provided by RefSeq, Jul 2008]
MIR3972 (HGNC:41876): (microRNA 3972) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.02).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.678 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_016233.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PADI3
NM_016233.2
MANE Select
c.1555+1330G>C
intron
N/ANP_057317.2
MIR3972
NR_039768.1
n.*231G>C
downstream_gene
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PADI3
ENST00000375460.3
TSL:1 MANE Select
c.1555+1330G>C
intron
N/AENSP00000364609.3
MIR3972
ENST00000582732.1
TSL:6
n.*231G>C
downstream_gene
N/A

Frequencies

GnomAD3 genomes
AF:
0.559
AC:
85046
AN:
152006
Hom.:
24341
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.684
Gnomad AMI
AF:
0.609
Gnomad AMR
AF:
0.521
Gnomad ASJ
AF:
0.379
Gnomad EAS
AF:
0.365
Gnomad SAS
AF:
0.511
Gnomad FIN
AF:
0.527
Gnomad MID
AF:
0.440
Gnomad NFE
AF:
0.526
Gnomad OTH
AF:
0.535
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.560
AC:
85165
AN:
152124
Hom.:
24396
Cov.:
34
AF XY:
0.559
AC XY:
41536
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.684
AC:
28405
AN:
41514
American (AMR)
AF:
0.522
AC:
7975
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.379
AC:
1312
AN:
3466
East Asian (EAS)
AF:
0.366
AC:
1894
AN:
5180
South Asian (SAS)
AF:
0.510
AC:
2463
AN:
4826
European-Finnish (FIN)
AF:
0.527
AC:
5572
AN:
10568
Middle Eastern (MID)
AF:
0.432
AC:
127
AN:
294
European-Non Finnish (NFE)
AF:
0.526
AC:
35729
AN:
67976
Other (OTH)
AF:
0.538
AC:
1133
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1898
3796
5694
7592
9490
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
724
1448
2172
2896
3620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.548
Hom.:
2884
Bravo
AF:
0.564
Asia WGS
AF:
0.518
AC:
1805
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.14
DANN
Benign
0.50
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2977299; hg19: chr1-17604701; API